Background: The quality of oxytocin and misoprostol, the most widely used uterotonics for postpartum haemorrhage (PPH) management, suffer supply chain challenges and climactic susceptibilities.
Aim: To describe a supply chain strengthening programme for introducing heat-stable Carbetocin (HSC), to health facilities in Kano, Lagos and Niger states.
Method: Human-centred design (HCD) was employed to uncover uterotonics supply chain challenges and to identify priority interventions across a market-shaping value chain to facilitate the rollout of HSC.